Evidence map›Paper›PMID 42198082›Full record

ArticleSensors (Basel, Switzerland)2026

An EEG-Based Edge-AI Framework for Alzheimer's and Creutzfeldt-Jakob Disease Classification.

Muhammad Suffian, Cosimo Ieracitano, Nadia Mammone, Angelo Pascarella, Edoardo Ferlazzo, Francesco Carlo Morabito

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Muhammad SuffianDICEAM, Mediterranea University of Reggio Calabria, 89125 Reggio Calabria, Italy.ORCID 0000-0002-1946-285X
Cosimo IeracitanoDICMaPI, University of Naples "Federico II", 80125 Naples, Italy.
Nadia MammoneDICEAM, Mediterranea University of Reggio Calabria, 89125 Reggio Calabria, Italy.ORCID 0000-0003-4962-3500
Angelo PascarellaDepartment of Medical and Surgical Sciences, Magna Græcia University of Catanzaro, 88100 Catanazaro, Italy.ORCID 0000-0002-0085-9494
Edoardo FerlazzoDepartment of Medical and Surgical Sciences, Magna Græcia University of Catanzaro, 88100 Catanazaro, Italy.
Francesco Carlo MorabitoDICEAM, Mediterranea University of Reggio Calabria, 89125 Reggio Calabria, Italy.ORCID 0000-0003-0734-9136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Electroencephalography (EEG) has emerged as a promising non-invasive tool for the diagnosis of neurodegenerative disorders, and artificial intelligence (AI) has shown significant potential in this domain, as demonstrated by recent studies. However, strong inter-subject variability remains a major challenge, limiting the ability of AI-based models to learn disease-specific features that generalize across individuals, thereby hindering the development of clinically deployable subject-independent systems. In this work, we propose a cross-subject, AI-based EEG classification framework to distinguish between Alzheimer's disease (AD), Creutzfeldt-Jakob disease (CJD), and healthy control subjects using clinical EEG data collected from a local hospital. A lightweight hybrid deep learning model is developed, combining a two-layer one-dimensional convolutional neural network with a two-layer Transformer encoder to capture both local temporal patterns and long-range dependencies in EEG signals. The proposed model achieves an average classification accuracy of 97%, representing a 3% improvement over a baseline model evaluated on a cohort of 36 subjects. To assess deployment feasibility in real-time clinical settings, the trained model is implemented and evaluated on an edge-AI platform (NVIDIA Jetson AGX Orin), demonstrating energy efficiency for the inference with a compact model footprint. These results indicate that the proposed approach provides an accurate, efficient, and practically deployable solution for subject-independent EEG-based classification of neurological disorders.

Indexed as

Alzheimer DiseaseArtificial IntelligenceCreutzfeldt-Jakob SyndromeElectroencephalographyAlgorithmsConvolutional Neural NetworksDeep LearningFemaleHumansNeural Networks, ComputerSignal Processing, Computer-AssistedAlzheimer’s disease (AD)brain-computer interfaceconvolutional neural networksCreutzfeldt–Jakob disease (CJD)edge-AIelectroencephalography (EEG)green AItransformers

Identifiers

PMID42198082
PMCPMC13211057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.